Metastatic dormancy in breast cancer depends on CD39+ PD-1+ CD8+ T cells Contributor Nature Comms Behind the paper Metastatic dormancy in breast cancer depends on CD39+ PD-1+ CD8+ T cells Paulino Tallón de Lara Feb 09, 2021
The unexpected journey for targeted therapy in T-ALL Contributor Nature Cancer Behind the paper The unexpected journey for targeted therapy in T-ALL August John Feb 04, 2021
The single-cell transcriptomic landscape of peripheral blood and tumour derived from patients with nasopharyngeal carcinoma Contributor Nature Comms Behind the paper The single-cell transcriptomic landscape of peripheral blood and tumour derived from patients with nasopharyngeal carcinoma Yang Liu Feb 04, 2021
Cyclodextrin-based host-guest drug delivery system paves a way for synergetic intervention of tumor progression and inflammatory microenvironment against colorectal cancer Contributor Nature Comms Behind the paper Cyclodextrin-based host-guest drug delivery system paves a way for synergetic intervention of tumor progression and inflammatory microenvironment against colorectal cancer +1 Guping Tang and 1 other Feb 04, 2021
Identifying genetic factors driving disease progression in chronic lymphocytic leukemia Contributor Nature Comms Behind the paper Identifying genetic factors driving disease progression in chronic lymphocytic leukemia James Allan Feb 03, 2021
Improvements in bone mineral density after 5 years of anastrozole use in women at high risk of developing breast cancer Contributor BJC Behind the paper Improvements in bone mineral density after 5 years of anastrozole use in women at high risk of developing breast cancer Ivana Sestak Feb 01, 2021
Targeting Metastatic Ewing Sarcoma via YAP/TAZ Inhibition Contributor Oncogenesis Behind the paper Targeting Metastatic Ewing Sarcoma via YAP/TAZ Inhibition Lisa Bierbaumer Jan 29, 2021
Activation of P2RX7 boosts antitumor immune responses and sensitizes tumors to immunotherapy Contributor Nature Comms Behind the paper Activation of P2RX7 boosts antitumor immune responses and sensitizes tumors to immunotherapy Serena Janho dit Hreich Jan 29, 2021
Contributor BJC Behind the paper Subsequent cancer risk among retinoblastoma survivors Sara J. Schonfeld Jan 27, 2021
Contributor Oncogene Behind the paper Cancer Researchers and Cancer Patients Communicating about Basic Science +3 Ravi Dhawan and 3 others Jan 26, 2021
Genetic link between premenopausal hormones and breast cancer risk Contributor BJC Behind the paper Genetic link between premenopausal hormones and breast cancer risk Nichola Johnson Jan 26, 2021
Biomolecular Condensation Drives Oncogenic Gene Expression Contributor Nature Structural Mol Biol Behind the paper Biomolecular Condensation Drives Oncogenic Gene Expression +1 Florian Grebien and 1 other Jan 22, 2021
In vivo synthetic lethal screen identifies drug synergies with immune checkpoint inhibitors Contributor Behind the paper In vivo synthetic lethal screen identifies drug synergies with immune checkpoint inhibitors +1 Dan Theodorescu and 1 other Jan 19, 2021
Epigenetics as a new target for treatment of bone disease in multiple myeloma Contributor Nature Comms Behind the paper Epigenetics as a new target for treatment of bone disease in multiple myeloma +2 Esteban Ballestar and 2 others Jan 18, 2021
Ruxolitinib discontinuation syndrome: incidence, risk factors and management in 251 patients with myelofibrosis Contributor Blood Cancer Behind the paper Ruxolitinib discontinuation syndrome: incidence, risk factors and management in 251 patients with myelofibrosis Francesca Palandri Jan 15, 2021
Next generation of IL-2 complexes Contributor Nature Comms Behind the paper Next generation of IL-2 complexes Dilara Sahin Jan 14, 2021
Contributor Leukemia Behind the paper, COVID-19 High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib Tiziano Barbui Jan 13, 2021
Understanding genomic factors contributing to disease progression in smoldering multiple myeloma Contributor Blood Cancer Nature Comms Behind the paper Understanding genomic factors contributing to disease progression in smoldering multiple myeloma Brian Walker Jan 12, 2021
Polygenic risk scores improve cancer risk prediction and stratification Contributor Nature Comms Behind the paper Polygenic risk scores improve cancer risk prediction and stratification Linda Kachuri Jan 11, 2021
Co-mutations, mutation order and clone size concur to determine disease phenotype of SRSF2-mutated neoplasms Contributor Blood Cancer Leukemia Nature Behind the paper Co-mutations, mutation order and clone size concur to determine disease phenotype of SRSF2-mutated neoplasms Gabriele Todisco Jan 11, 2021
